208 related articles for article (PubMed ID: 36122307)
21. Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.
Khan I; Waqas M; Shamim MS
J Pak Med Assoc; 2017 May; 67(5):816-817. PubMed ID: 28507382
[TBL] [Abstract][Full Text] [Related]
22. IDH-mutant giant cell glioblastoma: A neglected tumor variant?
Leske H; Brandal P; Rushing EJ; Niehusmann P
Clin Neuropathol; 2017; 36(6):293-295. PubMed ID: 29035191
[No Abstract] [Full Text] [Related]
23. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
Armocida D; Frati A; Salvati M; Santoro A; Pesce A
Clin Neurol Neurosurg; 2020 Nov; 198():106126. PubMed ID: 32861131
[TBL] [Abstract][Full Text] [Related]
24. Gemistocytes in newly diagnosed glioblastoma multiforme: Clinical significance and practical implications in the modern era.
Laviv Y; Berkowitz S; Kanner AK; Fichman S; Benouaich-Amiel A; Siegal T; Yust-Katz S
J Clin Neurosci; 2021 Jun; 88():120-127. PubMed ID: 33992170
[TBL] [Abstract][Full Text] [Related]
25. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma.
Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW
J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature.
Montemurro N
J Neurol Surg A Cent Eur Neurosurg; 2020 Jan; 81(1):64-70. PubMed ID: 31550738
[TBL] [Abstract][Full Text] [Related]
28. Massive dissemination of adult glioblastomas.
Willard N; Kleinschmidt-DeMasters BK
Clin Neuropathol; 2015; 34(6):330-42. PubMed ID: 26308254
[TBL] [Abstract][Full Text] [Related]
29. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
[TBL] [Abstract][Full Text] [Related]
30. MGMT Promoter Methylation Status Is Not Related to Histological or Radiological Features in IDH Wild-type Glioblastomas.
Mikkelsen VE; Dai HY; Stensjøen AL; Berntsen EM; Salvesen Ø; Solheim O; Torp SH
J Neuropathol Exp Neurol; 2020 Aug; 79(8):855-862. PubMed ID: 32688383
[TBL] [Abstract][Full Text] [Related]
31. Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.
Wang Z; Bao Z; Yan W; You G; Wang Y; Li X; Zhang W
J Exp Clin Cancer Res; 2013 Aug; 32(1):59. PubMed ID: 23988086
[TBL] [Abstract][Full Text] [Related]
32. The Multifunctional Role of EMP3 in the Regulation of Membrane Receptors Associated with IDH-Wild-Type Glioblastoma.
Martija AA; Pusch S
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067658
[TBL] [Abstract][Full Text] [Related]
33. Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.
Safaee M; Fakurnejad S; Bloch O; Clark AJ; Ivan ME; Sun MZ; Oh T; Phillips JJ; Parsa AT
PLoS One; 2015; 10(2):e0111532. PubMed ID: 25714433
[TBL] [Abstract][Full Text] [Related]
34. Molecular characteristics and clinical features of multifocal glioblastoma.
Dono A; Wang E; Lopez-Rivera V; Ramesh AV; Tandon N; Ballester LY; Esquenazi Y
J Neurooncol; 2020 Jun; 148(2):389-397. PubMed ID: 32440969
[TBL] [Abstract][Full Text] [Related]
35.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
36. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
37. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
38. Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis.
Stewart J; Sahgal A; Chan AKM; Soliman H; Tseng CL; Detsky J; Myrehaug S; Atenafu EG; Helmi A; Perry J; Keith J; Jane Lim-Fat M; Munoz DG; Zadeh G; Shultz DB; Das S; Coolens C; Alcaide-Leon P; Maralani PJ
Technol Cancer Res Treat; 2022; 21():15330338221109650. PubMed ID: 35762826
[No Abstract] [Full Text] [Related]
39. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
[TBL] [Abstract][Full Text] [Related]
40. TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
Williams EA; Miller JJ; Tummala SS; Penson T; Iafrate AJ; Juratli TA; Cahill DP
Acta Neuropathol Commun; 2018 Oct; 6(1):106. PubMed ID: 30333046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]